Arts Way Manufacturing vs Jewett Cameron Trading
ARTW and JCTC side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ARTW and JCTC compare
Arts Way Manufacturing is the larger company, worth 1.4 times as much as Jewett Cameron Trading ($14.5M against $10.2M).
Arts Way Manufacturing grew revenue faster over the last twelve months (4.5% versus −10.7% for Jewett Cameron Trading).
Arts Way Manufacturing keeps more of each dollar of sales as profit, with a net margin of −1.6% compared with −20.9% at Jewett Cameron Trading.
Jewett Cameron Trading scores higher on the StockData Score (8 against 6 for Arts Way Manufacturing), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ARTW | JCTC |
|---|---|---|
| Size and price | ||
| Market cap | $14.5M | $10.2M |
| Share price | $2.78 | $2.90 |
| Change, 1 year | 12.9% | 14.6% |
| Change, 5 years | −24.9% | −73.1% |
| Beta (5Y) | 0.53 | 0.26 |
| Employees | 66 | 45 |
| StockData Score | ||
| Total score | 6 | 8 (better) |
| Valuation score | 1 | 3 (better) |
| Growth score | 1 (better) | 0 |
| Performance score | 0 | 0 |
| Health score | 4 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.6× | 0.3× (better) |
| P/B | 1.1× | 0.7× (better) |
| EV/EBITDA | 21.0× | – |
| P/FCF | – | 10.7× |
| FCF yield | −7.2% | 9.3% (better) |
| Fair value | $2.21 | $7.86 |
| Margin of safety | −25.9% | 63.1% (better) |
| Growth | ||
| Revenue growth (TTM) | 4.5% (better) | −10.7% |
| Revenue growth, 5Y average | 0.50% (better) | −1.7% |
| Net income growth (TTM) | −117% | – |
| EPS growth (TTM) | −118% | – |
| Profitability | ||
| Gross margin | 26.0% (better) | 8.1% |
| Operating margin | −0.09% (better) | −18.0% |
| Net margin | −1.6% (better) | −20.9% |
| FCF margin | −4.1% | 2.4% (better) |
| Return on equity | −3.0% (better) | −43.7% |
| Return on invested capital | −0.11% (better) | −31.6% |
| Financial health | ||
| Debt / equity | 0.17 (better) | 0.00 |
| Net debt / EBITDA | 2.94 | – |
| Interest coverage | −0.0× | – |
| Current ratio | 1.71 | – |
| Altman Z-score | 2.44 | 3.55 (better) |
| Piotroski F-score | 4 (better) | 1 |
| Dividends and buybacks | ||
| Buyback yield | 0.01% | – |
| Shareholder yield | 0.01% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 7.2% | 13.8% |
| Held by insiders | 51.8% | 63.3% |
| Insider net buying, 12 months | – | $410K |
| Short interest, % of float | 0.86% | 1.7% |
Go deeper
- ARTW stock overview
- ARTW income statement
- ARTW valuation and score
- JCTC stock overview
- JCTC income statement
- JCTC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.